Berkeley Lights, Inc.

Berkeley Lights, Inc. engages in rapid development and commercialization of biotherapeutics and other cell-based products. Its platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. It operates through the following geographical segments: North America, Asia Pacific, and Europe. The company was founded by Igor Y. Khandros, William H. Davidow, Michael E. Marks, and Ming C. Wu on April 5, 2011 and is headquartered in Emeryville, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PhenomeX is enabling researchers to take advantage of each cell's full potential and launch the next phase of functional cell biology that will improve human health. We give researchers the most thorough understanding of how cells function and a detailed picture of each cell's behaviour.

LOS ANGELES--(BUSINESS WIRE)---- $BLI #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Berkeley Lights Inc. (“Berkeley Lights ” or the “Company”) (NASDAQ: BLI) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Berkeley Lights investments or would like to inquire about potentially pursuing claims to recover your loss under the fed

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Berkeley Lights Inc. (BLI) on Behalf of Investors

A scathing set of tweets from a short-seller leads to an investor exodus.

Why Berkeley Lights Stock Is Plummeting Today

Boston, Massachusetts--(Newsfile Corp. - September 15, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Berkeley Lights, Inc. (NASDAQ: BLI) ("Berkeley Lights" or the "Company"), a "digital cell biology company" with headquarters in Emeryville, California. In July 2020, Berkeley Lights closed its initial public offering ("IPO"), in which the Company sold 9,315,000 shares of common stock (which included 1,215,000 shares that were sold pursuant to...

Berman Tabacco Investigates Potential Securities Claims Against Berkeley Lights, Inc. (BLI)

LOS ANGELES--(BUSINESS WIRE)---- $BLI #investors--The Law Offices of Frank R. Cruz Announces Investigation of Berkeley Lights Inc. (BLI) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Berkeley Lights Inc. (BLI) on Behalf of Investors

Scorpion Capital, an activist short seller, is calling out Berkely Lights (BLI) stock as a fraud in a new report and we've got the details. The post BLI Stock Alert: Why Scorpion Capital Calls Berkely Lights a Troubling Pump and Dump VC Scam appeared first on InvestorPlace.

BLI Stock Alert: Why Scorpion Capital Calls Berkely Lights a Troubling Pump and Dump VC Scam

Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies

Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors

EMERYVILLE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.

Berkeley Lights to Participate in the Morgan Stanley Global Healthcare Conference

Signify Health

1Life Healthcare

Cathie Wood and her ARK Investment Management firm have made no secret of their investment strategy: find those companies that have a product or service that could change the way the world works.

ARK Investment Buys the Dips in 1Life, Berkeley Lights, Signify Health

The company fell just shy of analyst estimates in its latest reported quarter.

Why Berkeley Lights Wilted on Wednesday

Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q2 2021 Results - Earnings Call Transcript

Bayer AG

Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed base to 92 platforms, with seven new direct placements shipped in the quarter.

Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates

Second quarter revenue grew 82% year over year Second quarter revenue grew 82% year over year

Berkeley Lights Reports Second Quarter 2021 Financial Results

Agreement debuts Berkeley Lights' rapid high-throughput functional screening capability to accelerate and expand the discovery and development of Bayer Crop Science's seeds and traits product pipeline Agreement debuts Berkeley Lights' rapid high-throughput functional screening capability to accelerate and expand the discovery and development of Bayer Crop Science's seeds and traits product pipeline

Berkeley Lights and Bayer announce a multi-year agreement aimed at revolutionizing the discovery of next-generation traits

Coinbase

FuboTV

Unity Software

Beam Therapeutics

We are beginning to see a decline in the number of June-quarter earnings reports. There are still plenty to sift through, but nothing like the numbers we have seen over the past several weeks.

Earnings Previews: Coinbase, FuboTV, Unity Software and More

Berkeley Lights, Inc. (BLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Berkeley Lights, Inc. (BLI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

EMERYVILLE, Calif., July 21, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) today announced a strategic collaboration with Thermo Fisher Scientific aimed at addressing challenges in commercial-scale viral vector manufacturing. The partnership, which began in December of 2020, brings together Berkeley Lights' leadership in functional biology characterization with Thermo Fisher's expertise in viral vector manufacturing and analytics. Together, the companies are collaborating on a next-generation workflow using the Berkeley Lights Platform to accelerate and improve the development of stable AAV (Adeno-Associated Viral) and LV (Lentiviral) vector producer cell lines.

Berkeley Lights announces technology collaboration to accelerate and improve gene therapy viral vector development and manufacturing

EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the second quarter 2021 before market open on Wednesday, August 11, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Berkeley Lights to Report Second Quarter 2021 Financial Results on August 11, 2021

Berkeley Lights, Inc. is a leading digital cell biology company developing advanced microfluidics-based technologies alongside other single-cell-based advancements. Berkeley Lights' core offering is their fully integrated end-to-end single-cell analytics platform which covers proprietary consumables including their OptoSelect chips, reagent kits, advanced automation systems, and application/workflow software.

Berkeley Lights: Optofluidic Technology Presents Strong Upside, May Redefine Therapeutic Development

During Q1, Berkeley Lights's (NASDAQ:BLI) reported sales totaled $18.63 million. Despite a 28.43% in earnings, the company posted a loss of $15.08 million.

Berkeley Lights Insights: Return On Capital Employed

EMERYVILLE, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the release of its TechAccess Subscription model to enable broader customer access to their cutting-edge, single-cell screening technology. The new offering brings requested volume and throughput flexibility to customers who want to access the company's cell line development and antibody discovery workflows. The all-inclusive subscription provides customers with a comprehensive suite of products, including a Beacon® system, software, consumables, service, support, and commercial use rights. Each TechAccess subscription has a renewable 1-year term and provides customers with the turnkey capacity they need and the financial benefits of no up-front capital expense. The all-inclusive offering also provides customers with innovation insurance, providing access to Berkeley Lights' latest technology features and capabilities at no additional cost.

Berkeley Lights releases subscription-based access program and signs first customers

EMERYVILLE, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating virtually in the upcoming William Blair 41st Annual Growth Stock Conference.

Berkeley Lights to Participate in the William Blair 41st Annual Growth Stock Conference

Berkeley Lights' (BLI) CEO Eric Hobbs on Q1 2021 Results - Earnings Call Transcript

Q1 2021 revenue increased 35% year over year Q1 2021 revenue increased 35% year over year

Berkeley Lights Reports First Quarter 2021 Financial Results

Gregory T. Lucier named Board Chairperson, succeeding Michael Marks

Berkeley Lights Announces Changes to Board of Directors

Berkeley Lights, Inc. (NASDAQ:BLI) is a digital cell biology company focused on the rapid development and commercialization of biotherapeutics and other cell-based products for customers.

News for Berkeley Lights, Inc. Stock (BLI)